888.00
+43.00
+(5.09%)
As of 11:09:52 AM CST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 5 | 12 | 12 |
| Avg. Estimate | 5.34B | 4.85B | 18.36B | 19.4B |
| Low Estimate | 5.11B | 4.67B | 18.09B | 18.06B |
| High Estimate | 6.22B | 5.02B | 19.25B | 23.15B |
| Year Ago Sales | 3.96B | 4.02B | 11.81B | 18.36B |
| Sales Growth (year/est) | 34.89% | 20.49% | 55.39% | 5.70% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NEM.MX | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | Scotiabank: Sector Perform to Sector Perform | 1/21/2025 |
| Initiated | CLSA: Underperform | 11/29/2024 |
| Maintains | Raymond James: Outperform to Outperform | 11/25/2024 |
| Upgrade | JP Morgan: Neutral to Overweight | 11/19/2024 |
| Downgrade | UBS: Buy to Neutral | 10/30/2024 |
| Maintains | Raymond James: Outperform to Outperform | 10/25/2024 |